U-Earth Biotech (Biotechnology, ESG) — Funding, Investors & Signals 2026

U-Earth Biotech

Making clean air a human right through unique nature-based air purification services and hyperhealth products.

Founded 2018

London, United Kingdom 16 employees Seed Biotechnology, ESG

U-Earth, a biotechnology startup founded in 2018, is focused on providing nature-based air purification services and hyperhealth products. The company's mission is encapsulated in their slogan, "Making clean air a human right through unique nature-based air purification services and hyperhealth products." U-Earth aims to address the urgent need for clean air by offering cutting-edge solutions through its Pure Air Zone project and U-Earth Store. The Pure Air Zone project sets a new air quality standard, allowing companies to create pure air environments while advancing their ESG goals. Additionally, U-Earth provides a range of hyper health products, from masks to supplements and skincare, through the U-Earth Store. With offices in London, Milan, and Bucarest, U-Earth is rapidly expanding, with plans for an office in the US in the near future. The company has already garnered interest from prominent organizations, including Microsoft, Basf, and Discovery, as well as F1 and MotoGP teams, and Michelin star restaurants. U-Earth collaborates with companies across various industries, such as sports, healthcare, retail, and education, to address the pressing issue of air pollution. In terms of funding, U-Earth secured its last investment, a Seed Round, from iStarter on 01 November 2018. As U-Earth continues to expand its operations and impact, it remains a compelling player in the biotechnology industry, offering innovative solutions to combat air pollution and promote global health. To promote their mission, U-Earth has developed the Pure Air Zone App, offering a practical means for individuals and organizations to take the first step towards a cleaner world. With its commitment to providing clean air as a fundamental human right, U-Earth stands out as a promising player in the biotechnology sector, with a strong foundation and strategic partnerships supporting its endeavors.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round - U	••••••	1		01 Nov 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round - U

••••••

01 Nov 2018

FAQ About U-Earth Biotech

Making clean air a human right through unique nature-based air purification services and hyperhealth products.

U-Earth Biotech was founded in 2018.

U-Earth Biotech is headquartered in London, United Kingdom.

U-Earth Biotech operates in the following industries: Biotechnology, ESG.

U-Earth Biotech has approximately 16 employees.

U-Earth Biotech has completed 1 funding round. The latest funding stage is Seed.

U-Earth Biotech

General Information

Track U-Earth Biotech

Discover More

About U-Earth Biotech

Funding Rounds & Investors (1)

FAQ About U-Earth Biotech

Don't just browse. Track.